Bharat Biotech

The agreement is expected to generate US$50 million in savings and help protect one million more children with the RTS,S/AS01…

Bharat Biotech celebrated 30 years of scientific innovation, public health impact, and its continued commitment to protecting…

Bharat Biotech International has announced the launch of Nucelion Therapeutics, a newly established, Hyderabad-based Contract…

Vaccine has been demonstrated for the absence of reversion to virulence, safety, immunogenicity, protective efficacy and…

This year a total of 61 fellowships were awarded, for the first time, the fellowships were awarded to Industry leaders

New manufacturing facilities aim to bridge critical vaccine supply gap

BBIL will procure drug substances for the production of oral polio vaccines to be supplied within India and globally

The international agreement aims to build strong sectoral and cross-organisational collaborations to design novel methodologies to…

The UW-Madison Global One Health Center will focus on developing and producing novel vaccines in India

iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…